MedTrace Logo

Multi-Center Study Protocol: Impact of Sarcopenia in Early-Onset Colorectal Cancer.

NCT06868095 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-03-12

No results posted yet for this study

Summary

Sarcopenia's role in early-onset colorectal cancer (EOCRC), a subtype increasingly diagnosed in individuals under 50 years, has not yet been investigated according to recent literature.

Understanding the prevalence and prognostic impact of sarcopenia in EOCRC could inform tailored therapeutic approaches and improve patient outcomes.

Conditions

Interventions

OTHER

Surgical resection

Histologically confirmed EOCRC

Sponsors & Collaborators

  • Instituto de Investigación Biomédica de Salamanca

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-01
Primary Completion
2024-12-31
Completion
2025-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06868095 on ClinicalTrials.gov